The Invesco Perpetual UK Strategic Income Fund aims to produce an above average income with capital growth primarily through a portfolio of investments in UK companies.
Name | % Net Assets |
---|---|
BT | 5.6% |
British American Tobacco | 5.0% |
Imperial Tobacco | 4.7% |
GlaxoSmithKline | 4.4% |
Vodafone | 4.3% |
Reynolds American | 4.3% |
BG | 4.1% |
AstraZeneca | 3.9% |
BAE Systems | 3.6% |
Roche | 3.5% |
Key | % Net Assets |
---|---|
BT | 5.6% |
British American Tobacco | 5.0% |
Imperial Tobacco | 4.7% |
GlaxoSmithKline | 4.4% |
Other | 80.3% |
Date | 31-Jul-2020 |
---|---|
NAV | 126.79p |
Currency | GBP |
Change | -0.040p |
% | -0.03% |
YTD change | 126.79p |
YTD % | n/a |
Fund Inception | 25/06/1971 |
---|---|
Fund Manager | Mark Barnett |
TER | 1.69 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.67% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research